Boehringer sponsors UGC contest in diabetes awareness effort

Share this article:
Boehringer sponsors UGC contest in diabetes awareness effort
Boehringer sponsors UGC contest in diabetes awareness effort
Boehringer Ingelheim and the Diabetes Hands Foundation are seeking to raise awareness of diabetes with a contest inviting adults with diabetes to submit videos describing life with diabetes through one of the five senses.

Videos can run up to three minutes and “should express creativity and originality, be truthful and convey emotion in a compelling, evocative and personal way,” the sponsors said.

“Diabetes affects people's lives in profound and unexpected ways,” said Manny Hernandez, Diabetes Hands Foundation founder, in a statement. “We smell insulin, savor glucose tablets, feel the poke of lancing devices, react to our doctors words and see the life ahead of us. Diabetes is complex and we hope this video contest will help people express and share their diabetes experiences with the diabetes community as a whole as well as with people close to them.”

The contest, intended to coincide with World Diabetes Day on November 14, runs from September 28 to November 1. Three weekly finalists will be chosen based on unique views, average rating, quantity and quality of comments, creativity and originality. Prizes include kitchen scales, meter bags and books on living with diabetes.

Boehringer Ingelheim announced in June that it has compounds in Phase 2 and Phase 3 development for type 2 diabetes.
Share this article:

Email Newsletters

More in News

House bill would speed approval once EU OKs same product

House bill would speed approval once EU OKs ...

The Speeding Access to Already Approved Pharmaceuticals Act of 2014 would require FDA to expedite the review of pharmaceuticals that are already approved by the European Union

Allergan touts reorg, plans to lay off 13% of workforce

Allergan touts reorg, plans to lay off 13% ...

Allergan's second-quarter earnings, and a new round of cuts, are now part of the Botox maker's record as it seeks to remain independent.

Shire, AbbVie join forces for $55B

Shire, AbbVie join forces for $55B

The deal includes a $1.6-billion fee if AbbVie tries to walk away.